Concepedia

KyungMann Kim

KK

19

Publications

2.5K

Citations

18

H-Index

2000

Active since

Affiliations

University of Wisconsin–Madison(Current)

Dana-Farber Cancer Institute

University of Wisconsin Carbone Cancer Center

Michigan State University

University of Minnesota

KyungMann Kim is an author at University of Wisconsin–Madison specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2000–2020

19

Publications

19

Celecoxib for the Prevention of Sporadic Colorectal Adenomas

Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al. · New England Journal of Medicine · 2006 · 1K citations · Full text

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

Sandra J. Horning, Edie Weller, KyungMann Kim et al. · Journal of Clinical Oncology · 2004 · 352 citations

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

David Delgado, Jacquelyn A. Hank, Jill Kolesar et al. · Cancer Research · 2010 · 173 citations · Full text

, , +18

Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma

Fariba Navid, Paul M. Sondel, Raymond Barfield et al. · Journal of Clinical Oncology · 2014 · 158 citations · Full text

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

David M. King, Mark R. Albertini, Heidi Schalch et al. · Journal of Clinical Oncology · 2004 · 145 citations · Full text

Rows per page

1–5 of 19